U.S. market Closed. Opens in 23 hours 16 minutes

ORGO | Organogenesis Holdings Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-31
Revenue433.14M450.89M468.06M338.30M260.98M193.45MN/AN/A
Cost of Revenue106.48M105.02M114.20M87.32M75.95M68.81M4.59M208.70K
Gross Profit326.66M345.87M353.86M250.98M185.03M124.64M-4.59M-208.70K
Operating Expenses314.13M323.57M280.94M223.56M214.49M172.70M4.59M208.70K
Selling, General & Admin269.75M283.81M250.20M203.48M199.69M161.96M4.59M208.70K
Research & Development44.38M39.76M30.74M20.09M14.80M10.74MN/AN/A
Other Operating ExpensesN/A-13.00K-13.00K97.00K13.00K162.00KN/A208.70K
Operating Income12.53M22.30M72.92M27.41M-29.46M-51.56M-4.59M208.70K
Other Expenses / Income-2.13M-2.02M-9.13M-8.94M-10.85M-13.19M3.40M8.57M
Before Tax Income10.39M20.28M63.79M18.48M-40.30M-64.75M-2.09M-208.70K
Income Tax Expenses5.45M4.75M-31.12M530.00K150.00K84.00K-52.52K-440.21K
Net Income4.95M15.53M94.20M17.23M-40.45M-64.83M-2.09M-208.70K
Interest Expenses2.19M2.01M7.24M11.28M9.00M10.85M8.01M5.63M
Basic Shares Outstanding131.23M130.07M128.33M107.74M92.84M68.97M63.88M63.20M
Diluted Shares Outstanding132.75M132.38M133.66M111.36M92.84M69.32M63.88M63.20M
EBITDA36.03M40.32M87.00M37.23M-21.88M-46.92M-2.09M-1.75M
EBITDA Margin8.32%8.94%18.59%11.00%-8.38%-24.25%0.00%0.00%
EBIT12.58M22.29M70.32M29.04M-31.31M-53.89M5.86M4.98M
EBIT Margin2.90%4.94%15.02%8.59%-12.00%-27.86%0.00%0.00%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙